Trials / Sponsors / StemCyte, Inc.
StemCyte, Inc.
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition Long COVID, Post-COVID-19 Condition, Post-COVID Syndrome | Phase 3 | 2026-03-31 |
| Not Yet Recruiting | Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS) Acute Ischemic Stroke | Phase 2 | 2025-09-01 |
| Completed | Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome Long COVID, Post-COVID Syndrome, Post COVID-19 Condition | Phase 2 | 2023-05-04 |
| Terminated | Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training Spinal Cord Injuries | Phase 2 | 2022-02-22 |
| Available | Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Po Post-COVID-19 Condition, Post-COVID Condition, Post-COVID Syndrome | — | — |